Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.
The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).
Ranen
N G
NG
Department of Psychiatry and Human Behavior, Jefferson Medical College,Wills Eye Hospital, Philadelphia, PA, USA.
Pasternak
R E
RE
Rovner
B W
BW
D000368:Aged; D020117:Cisapride / Q000627:therapeutic use*; D005260:Female; D006212:Hallucinations / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D013577:Syndrome; D015354:Vision, Low / Q000150:complications*; D014796:Visual Perception
D017366:Serotonin Receptor Agonists; D020117:Cisapride